200 related articles for article (PubMed ID: 31331254)
21. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Jeffrey M; Goodsir CM; Race RE; Chesebro B
Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
[TBL] [Abstract][Full Text] [Related]
22. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
23. Role of interleukin-1 in prion disease-associated astrocyte activation.
Schultz J; Schwarz A; Neidhold S; Burwinkel M; Riemer C; Simon D; Kopf M; Otto M; Baier M
Am J Pathol; 2004 Aug; 165(2):671-8. PubMed ID: 15277240
[TBL] [Abstract][Full Text] [Related]
24. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
25. Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro.
Tribouillard-Tanvier D; Carroll JA; Moore RA; Striebel JF; Chesebro B
J Biol Chem; 2012 Feb; 287(7):4628-39. PubMed ID: 22179611
[TBL] [Abstract][Full Text] [Related]
26. Re-infection of the prion from the scrapie‑infected cell line SMB-S15 in three strains of mice, CD1, C57BL/6 and Balb/c.
Xiao K; Zhang BY; Zhang XM; Wang J; Chen C; Chen LN; Lv Y; Shi Q; Dong XP
Int J Mol Med; 2016 Mar; 37(3):716-26. PubMed ID: 26820255
[TBL] [Abstract][Full Text] [Related]
27. Microglia Are Critical in Host Defense against Prion Disease.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
[TBL] [Abstract][Full Text] [Related]
28. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
29. Molecular signatures in prion disease: altered death receptor pathways in a mouse model.
Giri RK
J Transl Med; 2024 May; 22(1):503. PubMed ID: 38802941
[TBL] [Abstract][Full Text] [Related]
30. Propagation of ovine prions from "poor" transmitter scrapie isolates in ovine PrP transgenic mice.
Thackray AM; Hopkins L; Lockey R; Spiropoulos J; Bujdoso R
Exp Mol Pathol; 2012 Feb; 92(1):167-74. PubMed ID: 22120785
[TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
Carroll JA; Chesebro B
Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
[TBL] [Abstract][Full Text] [Related]
32. Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions.
Gao C; Han J; Zhang J; Wei J; Zhang BY; Tian C; Zhang J; Shi Q; Dong XP
Mol Neurobiol; 2017 Jul; 54(5):3771-3782. PubMed ID: 27259989
[TBL] [Abstract][Full Text] [Related]
33. Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in Mice.
Chesebro B; Striebel J; Rangel A; Phillips K; Hughson A; Caughey B; Race B
mBio; 2015 Sep; 6(5):e01419-15. PubMed ID: 26396245
[TBL] [Abstract][Full Text] [Related]
34. Correlation between Bax overexpression and prion deposition in medulla oblongata from natural scrapie without evidence of apoptosis.
Lyahyai J; Bolea R; Serrano C; Monleón E; Moreno C; Osta R; Zaragoza P; Badiola JJ; Martín-Burriel I
Acta Neuropathol; 2006 Oct; 112(4):451-60. PubMed ID: 16804709
[TBL] [Abstract][Full Text] [Related]
35. Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.
Rangel A; Race B; Phillips K; Striebel J; Kurtz N; Chesebro B
Acta Neuropathol Commun; 2014 Jan; 2():8. PubMed ID: 24447368
[TBL] [Abstract][Full Text] [Related]
36. Neuroanatomical distribution of abnormal prion protein in naturally occurring atypical scrapie cases in Great Britain.
Moore SJ; Simmons M; Chaplin M; Spiropoulos J
Acta Neuropathol; 2008 Nov; 116(5):547-59. PubMed ID: 18797889
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.
Poli G; Corda E; Lucchini B; Puricelli M; Martino PA; Dall'ara P; Villetti G; Bareggi SR; Corona C; Vallino Costassa E; Gazzuola P; Iulini B; Mazza M; Acutis P; Mantegazza P; Casalone C; Imbimbo BP
Prion; 2012; 6(1):62-72. PubMed ID: 22453180
[TBL] [Abstract][Full Text] [Related]
38. CNS pathogenesis of prion diseases.
Brandner S
Br Med Bull; 2003; 66():131-9. PubMed ID: 14522855
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 expression is correlated with abnormal prion protein accumulation in murine scrapie.
Jin JK; Na YJ; Song JH; Joo HG; Kim S; Kim JI; Choi EK; Carp RI; Kim YS; Shin T
Neurosci Lett; 2007 Jun; 420(2):138-43. PubMed ID: 17531384
[TBL] [Abstract][Full Text] [Related]
40. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
